Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the accumulation of misfolded ...
ATH434 reduced functional decline vs placebo at Week 52 on MuSyCA, a newly described MSA composite scale -- Effects seen on both daily function ...
Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...
The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in ...
STING" molecular switch drives Alzheimer's brain inflammation. Blocking this switch protects synapses in new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results